Orenitram®, Remodulin®, and Tyvaso® are registered trademarks of United Therapeutics Corporation, and Tyvaso DPI™ is a trademark of United Therapeutics Corporation. Adcirca® is a registered trademark of Eli Lilly and Company. All other trademarks and registered trademarks are the property of their respective owners.